Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 28

Sort by

Sort Order Select

Journal Articles

Hematopoietic Stem Cell Transplant Utilization in Relapsed/Refractory Hodgkin Lymphoma: A Population Level Analysis of Statewide Claims Data

Anem Waheed, MD MPH, Angie Mae Rodday, PhD MS, Anita J Kumar, MD MS, Kenneth B. Miller, MD, Susan K Parsons, MD MRP

Blood (2018) 132 (Supplement 1): 4771.

https://doi.org/10.1182/blood-2018-99-111921

Published: 2018

Journal Articles

Improvements in Patient Outcomes with Autologous Stem Cell Transplantation for Multiple Myeloma over 25 Years at a Single Center

Sandy W. Wong, MD, Melissa Warner, BS, Alejandro Moreno-Koehler, MPH, Athena Kritharis, MD, Michael E Coyle, MD, Deborah Black, RN, BSN, Valerie Relias, PharmD, BCOP, Terry Fogaren, RN, BSN, Nancy Cody Lyons, NP, Francois Toka, NP-C, Denise Larivee, RN, Hedy Smith, MD PhD, Andrew M. Evens, DO, MSc, Grace Kao, MD, Kellie Sprague, MD, Andreas K. Klein, MD, Kenneth B. Miller, MD, Raymond L. Comenzo, MD

Blood (2015) 126 (23): 5496.

https://doi.org/10.1182/blood.V126.23.5496.5496

Published: 2015

Journal Articles

Colchicine Can be an Effective Adjunctive Treatment for Extensive Refractory Chronic-Graft-Versus-Host Disease

Sandy W. Wong, MD, Raymond L. Comenzo, MD, Todd F. Roberts, MD MSC, FRCP (C), Kellie Sprague, MD, Kenneth B. Miller, MD

Blood (2015) 126 (23): 5461.

https://doi.org/10.1182/blood.V126.23.5461.5461

Published: 2015

Journal Articles

Splenic Irradiation and a Reduced-Intensity Conditioning Regimen Prior to Allogeneic Stem-Cell Transplantation for Myelofibrosis

Ojas H. Vyas, MD, Esha Kaul, MD, Aaron S. Rosenberg, MD, Gunjan L Shah, MDMS, Urvi Ajay Shah, MD, Raymond L. Comenzo, MD, Grace Shih-Hui Kao, MD, Andrew M. Evens, DO, MSc, Hedy Smith, MDPhD, Andreas K. Klein, MD, Kenneth B. Miller, MD, Kellie A. Sprague, MD

Blood (2014) 124 (21): 3170.

https://doi.org/10.1182/blood.V124.21.3170.3170

Published: 2014

Journal Articles

Hepatitis B (HBV) Screening in Patients Receiving Rituximab: A Comprehensive Analysis Including Comparison of Adherence By Oncologists and Non-Oncologists

Aditi Puri, MD, Ryan L. Stevenson, MD, Jack Khouri, MD, Raymond L. Comenzo, MD, Grace Shih-Hui Kao, MD, Andreas K. Klein, MD, Kenneth B. Miller, MD, Aaron Rosenberg, MD MS, Hedy Smith, MDPhD, Kellie A. Sprague, MD, Valerie Relias, PharmD, Andrew M. Evens, DO, MSc

Blood (2014) 124 (21): 2595.

https://doi.org/10.1182/blood.V124.21.2595.2595

Published: 2014

Journal Articles

Photopheresis As Part of Conditioning Reduces Incidence of Severe Graft Versus Host Disease: Fourteen Year Follow-up of a Novel Reduced Intensity Regimen for Allogeneic Hematopoietic Stem Cell Transplantation

Esha Kaul, MD, Gunjan L Shah, MDMS, Aaron S. Rosenberg, MD, Raymond L. Comenzo, MD, Hedy Smith, MD PhD, Andrew M. Evens, DO, MSc, Furha I. Cossor, MD, Grace S. Kao, MD, Kenneth B. Miller, MD, Andreas K. Klein, MD, Kellie A. Sprague, MD

Blood (2014) 124 (21): 5924.

https://doi.org/10.1182/blood.V124.21.5924.5924

Published: 2014

Journal Articles

Clinicopathologic Characteristics Of Secondary Malignancies In Survivors Of Allogeneic Hematopoietic Stem Cell Transplantation In Patients With Hematologic Malignancies

Chakra P Chaulagain, MD, FACP, Esha Kaul, MD, Monika Pilichowska, MD, Andreas K. Klein, MD, Kellie Sprague, MD, Kenneth B. Miller, MD

Blood (2013) 122 (21): 5496.

https://doi.org/10.1182/blood.V122.21.5496.5496

Published: 2013

Journal Articles

Cost-Implications Of Comorbidity For Autologous Hematopoietic Stem Cell Transplantation (Auto HSCT) In Elderly Patients With Multiple Myeloma (MM) Using The SEER-Medicare Database

Gunjan L. Shah, MD MS, Aaron Winn, MPP, Andreas K. Klein, MD, Kellie Sprague, MD, Joshua T. Cohen, PhD, Kenneth B. Miller, MD, Susan K. Parsons, MD, MRP

Blood (2013) 122 (21): 1746.

https://doi.org/10.1182/blood.V122.21.1746.1746

Published: 2013

Journal Articles

Subcutaneous Bortezomib in Combination Regimens in Newly Diagnosed Patients with Myeloma or Systemic AL Amyloidosis: High Response Rates and Minimal Toxicity.

Gunjan L Shah, MD MS, Esha Kaul, MD, Shelly Fallo, RPh, Furha I. Cossor, MD MS, Hedy Smith, MD PhD, Andreas K. Klein, MD, Kenneth B. Miller, MD, Raymond L. Comenzo, MD

Blood (2012) 120 (21): 2968.

https://doi.org/10.1182/blood.V120.21.2968.2968

Published: 2012

Journal Articles

Outcomes in Allogeneic Hematopoietic Stem Cell Transplant Patients ≥ 60 Years of Age with a Novel Reduced Intensity Conditioning Regimen Incorporating Extracorporeal Photopheresis,

Furha I. Cossor, MD, Sandy Wong, MD, Kenneth B Miller, MD, Deborah Black, RN, Raymond L. Comenzo, MD, Andreas K. Klein, MD, Alanna Klekar, RN, Valerie Relias, PharmD, Hedy Smith, MD, PhD, Kellie Sprague, MD, Karen M Switkowski, MS, MPH, Richard A. Van Etten, MD PhD, Hans-Georg Klingemann, MD, PhD

Blood (2011) 118 (21): 4153.

https://doi.org/10.1182/blood.V118.21.4153.4153

Published: 2011

Journal Articles

Clofarabine for Cytoreduction Prior to Allogeneic Transplant Conditioning for Refractory Acute Myelogenous Leukemia

Deepa Jeyakumar, MD, Kellie Sprague, MD, Kenneth B. Miller, MD, Andreas K. Klein, MD, Hans-Georg Klingemann, MD, PhD

Blood (2011) 118 (21): 4506.

https://doi.org/10.1182/blood.V118.21.4506.4506

Published: 2011

Journal Articles

Allogeneic NK Cell Therapy After Autologous Stem Cell Transplant: Results of a Phase I Study

Hans-Georg Klingemann, MD, PhD, Carrie Grodman, RN, Andreas K. Klein, MD, Kellie Sprague, MD, Kenneth B. Miller, MD, Tarun Kewalramani, MD, Raymond L. Comenzo, MD, Neng Yu, MD, Marvin Duque, MD, Richard A. Van Etten, MD, PhD, David McKenna, MD

Blood (2010) 116 (21): 4299.

https://doi.org/10.1182/blood.V116.21.4299.4299

Published: 2010

Journal Articles

Outpatient Decitabine in Elderly Patients with Acute Myeloid Leukemia (AML).

Alexey V. Danilov, MD, PhD, Hedy Smith, MD, PhD, Valerie Relias, Kenneth B Miller, MD

Blood (2009) 114 (22): 4144.

https://doi.org/10.1182/blood.V114.22.4144.4144

Published: 2009

Journal Articles

ZAP-70 Disrupts Dipeptidyl Peptidase 2 (DPP2)-Regulated Quiescence in Chronic Lymphocytic Leukemia (CLL).

Alexey V. Danilov, MD, PhD, Olga Danilova, MD, PhD, Andreas Klein, MD, Jennifer Brown, MD, PhD, Arthur P. Rabinowitz, MD, Kenneth B Miller, MD, Brigitte T Huber, PhD

Blood (2009) 114 (22): 1251.

https://doi.org/10.1182/blood.V114.22.1251.1251

Published: 2009

Journal Articles

Treatment of myelodysplastic syndrome patients with erythropoietin with or without granulocyte colony-stimulating factor: results of a prospective randomized phase 3 trial by the Eastern Cooperative Oncology Group (E1996)

Peter L. Greenberg, Zhuoxin Sun, Kenneth B. Miller, John M. Bennett, Martin S. Tallman, Gordon Dewald, Elisabeth Paietta, Richard van der Jagt, Jessie Houston, Mary L. Thomas, David Cella, Jacob M. Rowe

Blood (2009) 114 (12): 2393–2400.

https://doi.org/10.1182/blood-2009-03-211797

Published: 2009

Includes: Supplemental data

Journal Articles

Comprehensive Highly Multiplexed Single-Tube Liquid Bead Microarray Assay for Constitutively Activated Tyrosine Kinases in Chronic Myeloproliferative Disorders.

Mark J. Roberts, MD, Yening Zhou, Ph.D., Kenneth B. Miller, M.D., German A. Pihan, M.D.

Blood (2007) 110 (11): 1551.

https://doi.org/10.1182/blood.V110.11.1551.1551

Published: 2007

Journal Articles

A Pilot Trial of Two Dose Levels of Rabbit Antithymocyte Globulin, (rATG), Thymoglobulin, as Part of a Myeloablative-Conditioning for a HLA Identical Matched Related Donor Stem Cell Transplant (SCT) with Cyclosporine (CsA) as Graft Versus Host Disease (GvHD) Prophylaxis.

Kenneth B. Miller, MD, Nelson J. Chao, MD, Hans A. Messner, MD,PhD, Steven C. Goldstein, MD, Vijay Reddy, MD,PhD, William Vaughan, MD, Steven Devine, MD, Scott D. Rowley, MD, Ned Waller, MD,PhD, Marcel Devetten, MD, Gary J. Schiller, MD

Blood (2006) 108 (11): 5369.

https://doi.org/10.1182/blood.V108.11.5369.5369

Published: 2006

Journal Articles

Addition of Bortezomib (Velcade) to AML Induction Chemotherapy Is Well Tolerated and Results in a High Complete Remission Rate.

Eyal C. Attar, MD, Daniel J. De Angelo, MD, PhD, Andres Sirulnik, MD, PhD, Martha Wadleigh, MD, Karen K. Ballen, MD, Kenneth B. Miller, MD, Ilene Galinsky, Donna Neuberg, PhD, Elizabeth Trehu, MD, David Schenkein, MD, Richard M. Stone, MD, Philip C. Amrein, MD

Blood (2005) 106 (11): 2782.

https://doi.org/10.1182/blood.V106.11.2782.2782

Published: 2005

Journal Articles

Mitoxantrone and Melphalan Conditioning Regimen for Autologous Peripheral Blood Stem Cell Transplantation in Adults with Acute Myelogenous Leukemia.

Kellie Sprague, MD, Vaishalee Padgaonkar, MD, Andreas K. Klein, MD, Geoffrey W. Chan, MD, Kenneth B. Miller, MD, Hans Klingemann, MD/PhD

Blood (2005) 106 (11): 5512.

https://doi.org/10.1182/blood.V106.11.5512.5512

Published: 2005

Journal Articles

Allogeneic Stem Cell Transplant (AlloSCT) for Hodgkin’s Lymphoma Which Has Relapsed Following Autologous SCT - Evidence for Potent Graft-Versus-Lymphoma Effect.

Andreas K. Klein, MD, Chan Geoffrey, MD, Kellie Sprague, MD, Kenneth B. Miller, MD, Francine Foss, MD

Blood (2004) 104 (11): 3327.

https://doi.org/10.1182/blood.V104.11.3327.3327

Published: 2004

NARROW

Hematopoietic Stem Cell Transplant Utilization in Relapsed/Refractory Hodgkin Lymphoma: A Population Level Analysis of Statewide Claims Data

Improvements in Patient Outcomes with Autologous Stem Cell Transplantation for Multiple Myeloma over 25 Years at a Single Center

Colchicine Can be an Effective Adjunctive Treatment for Extensive Refractory Chronic-Graft-Versus-Host Disease

Splenic Irradiation and a Reduced-Intensity Conditioning Regimen Prior to Allogeneic Stem-Cell Transplantation for Myelofibrosis

Hepatitis B (HBV) Screening in Patients Receiving Rituximab: A Comprehensive Analysis Including Comparison of Adherence By Oncologists and Non-Oncologists

Photopheresis As Part of Conditioning Reduces Incidence of Severe Graft Versus Host Disease: Fourteen Year Follow-up of a Novel Reduced Intensity Regimen for Allogeneic Hematopoietic Stem Cell Transplantation

Clinicopathologic Characteristics Of Secondary Malignancies In Survivors Of Allogeneic Hematopoietic Stem Cell Transplantation In Patients With Hematologic Malignancies

Cost-Implications Of Comorbidity For Autologous Hematopoietic Stem Cell Transplantation (Auto HSCT) In Elderly Patients With Multiple Myeloma (MM) Using The SEER-Medicare Database

Subcutaneous Bortezomib in Combination Regimens in Newly Diagnosed Patients with Myeloma or Systemic AL Amyloidosis: High Response Rates and Minimal Toxicity.

Outcomes in Allogeneic Hematopoietic Stem Cell Transplant Patients ≥ 60 Years of Age with a Novel Reduced Intensity Conditioning Regimen Incorporating Extracorporeal Photopheresis,

Clofarabine for Cytoreduction Prior to Allogeneic Transplant Conditioning for Refractory Acute Myelogenous Leukemia

Allogeneic NK Cell Therapy After Autologous Stem Cell Transplant: Results of a Phase I Study

Outpatient Decitabine in Elderly Patients with Acute Myeloid Leukemia (AML).

ZAP-70 Disrupts Dipeptidyl Peptidase 2 (DPP2)-Regulated Quiescence in Chronic Lymphocytic Leukemia (CLL).

Treatment of myelodysplastic syndrome patients with erythropoietin with or without granulocyte colony-stimulating factor: results of a prospective randomized phase 3 trial by the Eastern Cooperative Oncology Group (E1996)

Comprehensive Highly Multiplexed Single-Tube Liquid Bead Microarray Assay for Constitutively Activated Tyrosine Kinases in Chronic Myeloproliferative Disorders.

A Pilot Trial of Two Dose Levels of Rabbit Antithymocyte Globulin, (rATG), Thymoglobulin, as Part of a Myeloablative-Conditioning for a HLA Identical Matched Related Donor Stem Cell Transplant (SCT) with Cyclosporine (CsA) as Graft Versus Host Disease (GvHD) Prophylaxis.

Addition of Bortezomib (Velcade) to AML Induction Chemotherapy Is Well Tolerated and Results in a High Complete Remission Rate.

Mitoxantrone and Melphalan Conditioning Regimen for Autologous Peripheral Blood Stem Cell Transplantation in Adults with Acute Myelogenous Leukemia.

Allogeneic Stem Cell Transplant (AlloSCT) for Hodgkin’s Lymphoma Which Has Relapsed Following Autologous SCT - Evidence for Potent Graft-Versus-Lymphoma Effect.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only